10794 related articles for article (PubMed ID: 10972550)
1. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor.
Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K
Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550
[TBL] [Abstract][Full Text] [Related]
2. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
3. Peripheral primitive neuroectodermal tumors. CT and MRI evaluation.
Ibarburen C; Haberman JJ; Zerhouni EA
Eur J Radiol; 1996 Feb; 21(3):225-32. PubMed ID: 8777915
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
[TBL] [Abstract][Full Text] [Related]
5. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance angiography without contrast enhancement medium in bone and soft tissue tumors.
Doi H; Ono A; Kawai A; Morimoto Y; Kunisada T; Nakata E; Ozaki T
Oncol Rep; 2006 Mar; 15(3):681-5. PubMed ID: 16465430
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
[TBL] [Abstract][Full Text] [Related]
8. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
[TBL] [Abstract][Full Text] [Related]
10. [31P-MR spectroscopy of bone and soft tissue lesions].
Kitagawa A; Saeki M; Imamura K; Ohashi K; Ishikawa T; Nakajima H; Takagi M
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1017-24. PubMed ID: 8587841
[TBL] [Abstract][Full Text] [Related]
11. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
12. Post-treatment complications of soft tissue tumours.
Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
[TBL] [Abstract][Full Text] [Related]
13. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
15. Malignant fibrous histiocytoma with special reference to its differential diagnosis.
Ushigome S; Hirota T
Acta Pathol Jpn; 1980 Sep; 30(5):799-813. PubMed ID: 6255739
[TBL] [Abstract][Full Text] [Related]
16. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
[TBL] [Abstract][Full Text] [Related]
17. New approaches in the diagnosis of small-cell round tumors of bone and soft tissue.
Petrov SV; Machado I; Boulytcheva IV; Noguera R; Pellin A; Bacchini P; Bertoni F; Llombart-Bosch A
Arkh Patol; 2009; 71(1):34-40. PubMed ID: 19514357
[TBL] [Abstract][Full Text] [Related]
18. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study between magnetic resonance imaging and histological findings of bone and soft tissue tumors].
Itoh K
Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):899-914. PubMed ID: 8551093
[TBL] [Abstract][Full Text] [Related]
20. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
